Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Galanos A, Vlahos L (2007) Comparison of pain quality descriptors in cancer patients with nociceptive and neuropathic pain. In Vivo 21:93–97
2. Portenoy RK, Miransky J, Thaler HT, Hornung J, Bianchi C, Cibas-Kong I, Feldhamer E, Lewis F, Matamoros I, Sugar MZ et al (1992) Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect. Cancer 70:1616–1624. https://doi.org/10.1002/1097-0142(19920915)70:6%3c1616::AID-CNCR2820700630%3e3.0.CO;2-7
3. (2018) WHO guidelines approved by the guidelines review committee WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. World Health Organization ©World Health Organization 2018., Geneva. Available from: https://www.who.int/publications/i/item/9789241550390. Accessed May 21, 2022
4. Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA (2011) Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev CD007519. https://doi.org/10.1002/14651858.cd007519.pub2
5. Yoon DM, Yoon KB, Baek IC, Ko SH, Kim SH (2018) Predictors of analgesic efficacy of neurolytic celiac plexus block in patients with unresectable pancreatic cancer: the importance of timing. Support Care Cancer 26:2023–2030. https://doi.org/10.1007/s00520-018-4043-2